IPHA_logoIPHA_logoIPHA_logoIPHA_logo
Contact Us Membership Useful Links
  • About Us
    • Overview
    • Our Role
    • Executive Team
    • Membership
    • Affiliate Programme
    • Member Services
    • President and Vice Presidents
    • Board of Directors
    • Prescription Medicines Division Strategy Board
    • Self-Care Division
    • Advisory Forums
    • International Activities
  • Our Policies
    • Overview
    • Self-Care
    • Biologics
    • Health Technology Assessment
    • Transfers of Value
  • About the industry
    • Overview
    • Clinical Trials in Ireland
    • Contribution to the Irish Economy
    • Corporate Responsibility
    • Counterfeit Medicines
    • Information to Patients
    • Key Facts
    • Medicines Safety
    • Price of Medicines
    • Promotion of Medicines
    • Regulatory Science Ireland
    • Research and Development
    • Supply and Reimbursement
    • The State Medicines Bill
    • Value of Medicines
  • Publications and Submissions
    • Overview
    • IPHA Codes
    • Advisory Board Meetings
    • Submissions
    • IPHA publications
    • Videos
  • News
    • Latest News
    • IPHA Events
    • Campaigns
    • Job Opportunities
  • About Us
    • Overview
    • Our Role
    • Executive Team
    • Membership
    • Affiliate Programme
    • Member Services
    • President and Vice Presidents
    • Board of Directors
    • Prescription Medicines Division Strategy Board
    • Self-Care Division
    • Advisory Forums
    • International Activities
  • Our Policies
    • Overview
    • Self-Care
    • Biologics
    • Health Technology Assessment
    • Transfers of Value
  • About the industry
    • Overview
    • Contribution to the Irish Economy
    • Corporate Responsibility
    • Counterfeit Medicines
    • Information to Patients
    • Key Facts
    • Medicines Safety
    • Price of Medicines
    • Promotion of Medicines
    • Regulatory Science Ireland
    • Research and Development
    • Supply and Reimbursement
    • The State Medicines Bill
    • Value of Medicines
  • Publications and Submissions
    • Overview
    • IPHA Codes
    • Submissions
    • IPHA publications
    • Videos
  • News
    • Overview
    • Job Opportunities
    • Latest News
    • IPHA Events
    • Campaigns
  • Contact Us
  • Membership
  • Useful Links
  • Home
  • About Us
  • Contact Us
  • Home
  • News
  • Latest News
  • Uncategorized
  • AbbVie film welcomed as part of ‘Innovate For Life’

AbbVie film welcomed as part of ‘Innovate For Life’

January 10, 2021

January 10,, 2021

AbbVie film welcomed as part of ‘Innovate For Life’

The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed a film highlighting the Irish work of AbbVie, one of the world’s leading biopharmaceutical companies.

The new film showcases the career and life opportunities offered by the west of Ireland.

It is part of IPHA’s ‘Innovate For Life’ campaign, a series of films featuring biopharmaceutical companies including Pfizer, Janssen, Takeda, Novartis, Astellas and AbbVie. The films bring out the many dimensions of the biopharmaceutical industry’s impact in Ireland. AbbVie’s footprint in the northwest, where it has two sites in Sligo, features in the latest film in the campaign.

Michael Lohan, Head of Life Sciences at IDA Ireland, said: “The foreign direct investment biopharmaceutical sector has a hugely significant impact on the Irish economy. The sector has demonstrated a commitment to Ireland through continued investment, longevity and resilience. The industry has demonstrated real leadership in the global fight against COVID-19 through collaboration on research to dynamic supply chain responses, directly supporting the demands placed on the healthcare system and wider society. The ‘Innovate For Life’ campaign helps to tell that impact and value story – a powerful narrative for a consequential industry.”

The AbbVie film, which is available to view online, shows the northwest at its best. Outside the workplace, it shows surfing and hiking destinations are just minutes away, although many of AbbVie’s employees simply enjoy the allure of a more serene lifestyle and the beautiful views of the northwest.

The campaign, #InnovateForLife, opens a window on the world of medicines innovation right across the lifecycle – from discovery and development through to manufacturing and adoption by the health services. The campaign is organised into three pillars – Patients, Places and Pioneers – capturing the economic and societal impact of the biopharmaceutical industry on patients’ lives, on communities, and on science and medicines development.

Bernard Mallee, Director of Communications and Advocacy at IPHA, said: “We are delighted to launch inspiring new content for ‘Innovate For Life’ – the campaign IPHA leads which draws together the many strands of our impact in patients’ lives, in communities across the country, and in science for the development of new treatments. During COVID-19, the role of our industry in the economy and in healthcare has been starkly revealed. Like other biopharmaceutical innovators, including Pfizer, Janssen, Takeda, Novartis and Astellas, AbbVie is part of ‘Innovate For Life’. We are proud of AbbVie’s contribution to the industry. It is making medicines for global supply, creating jobs in the region, improving patients’ health outcomes and helping to position Ireland for foreign direct investments. The new film helps to tell that important story for AbbVie as part of a wider industry narrative.”

AbbVie’s film can be viewed here

All films are available at Innovate For Life

 

Share

Related posts

March 25, 2021

New medicines generate €52bn in socioeconomic value for Ireland, says WifOR study for IPHA


Read more
February 28, 2021

IPHA urges IP protection as world marks Rare Disease Day


Read more
February 24, 2021

Just 6% of people will refuse COVID-19 vaccine, says Ipsos MRBI tracker survey for IPHA


Read more

Terms and Conditions    |    Privacy Statement    |    Sitemap    |    Cookies


Registered Number: 254776 Registered Address: 7 Clanwilliam Terrace, Dublin 2, D02 CC64

© 2020 IPHA